News

Lack of HIV awareness and misconceptions about PrEP may be barriers to implementing prevention programs among female sex workers in China, according to a recent study.

The latest on this ever-changing and complex outbreak.

The adjusted odds for having oropharyngeal gonorrhea were 1.46-fold for men with ≥4 kissing-only partners and 1.81-fold for men with ≥4 kissing-with-sex partners.

At MAD-ID 2019, Alison Lew, PharmD, spoke about her research on oral vancomycin prophylaxis to reduce CDI recurrence.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of May 12, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

According to the CDC, 28% of the Salmonella cases in this outbreak occurred in children under the age of 5 years.

With a shortage in specialists, the service could help address an issue that costs health care billions of dollars a year.

A new study finds involving bedside nurses in antimicrobial stewardship and infection prevention can yield major results in a short amount of time.

Women are quite receptive to learning about PrEP in the right environment, but some providers have a long way to go in terms of education.

A multifaceted intervention has tripled the rate of hepatitis C virus screening in a baby boomer population.

A new study gives hope in the fight against multidrug-resistant bacteria.

Renee Ackley, PharmD, BCPS, discusses her research ceftazidime/avibactam and meropenem/vaborbactam for treatment of CRE infections.

Does pharmacist presence in an urgent care center have an effect on antibiotic prescribing practices?

Consumption of oysters from a Mexican estuary has led to infections caused by multiple pathogens, with some individuals infected by more than 1 bug.

Agreement between Gilead and Trump administration promises more drugs for at-risk patients.

Following a rise in sexually transmitted infection diagnoses in recent years, NIAID is awarding grants for research into syphilis, gonorrhea, and chlamydia vaccine candidates.

Contagion® editor-in-chief Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, recaps his presentations from MAD-ID 2019.

Treating men with UTIs for longer than 7 days shows no clinical benefits and is associated with increased risk of recurrence.

As clinician are growing interested in the use of extended infusion beta-lactams for gram-negative bacteremia, a team of investigators noticed that available data are unclear and solely focus on clinical cure and/or mortality outcomes.

At MAD-ID 2019, Monica V. Mahoney, PharmD, BCPS (AQID), BCIDP, presented a workshop on formulary management strategies in antimicrobial stewardship.

One company's bankruptcy sheds light on a deeply worrisome reality.

A study found that patients with complicated C diff infections were more likely to have been previously hospitalized with numerically less time between hospitalization and recent C diff episode.

Brandon J. Smith, MD, PharmD, describes a case of a patient who was treated for mycobacterial infection after ground-glass opacity was detected in her lung.

Ryan K. Shields, PharmD, MS, discusses his research presented at MAD-ID 2019 on T2Candida's place in rational antifungal management.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of May 5, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.